Adenovirus type 5 E1A immortalizes primary rat cells expressing wild- type p53

Microbiology and Immunology

Volumn 43, Issue 11, 1999, Pages 1037-1044

  Yamashita, Toshiharu ^a   Tonoki, Hidefumi ^b   Nakata, Daichi ^b   Yamano, Shigeru ^a   Segawa, Kaoru ^c   Moriuchi, Tetsuya ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenovirus E1A; Apoptosis; Immortalization; p53

Indexed keywords

AMINO ACID; PROTEIN P53;

ADENOVIRUS 5; AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE MUTATION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MOLECULAR CLONING; NONHUMAN; RAT;

EID: 0032707052     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb01233.x     Document Type: Article

References (58)

1. Bannister, A.J., and Kouzarides, T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643.
2. Chen, H., Ko, L.J., Jayaraman, L., and Prives, C. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10: 2438-2451.
3. Chiou, S.-K., Rao, L., and White, E. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14: 2556-2563.
4. Chomczynski, P., and Sacchi, N. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
5. Crook, T., Marston, N.J., Sara, E.A., and Vousden, K.H. 1994. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79: 817-827.
6. Debbas, M., and White, E. 1993. Wild-type p53 mediates apoptosis by E1A. which is inhibited by E1B. Genes Dev. 7: 546-554.
7. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Butel, J.S., and Bradley, A. 1992. Mice deficient for p53 are developmentary normal but susceptible to spontaneous tumours. Nature 356: 215-221.
8. Egan, C., Jelsma, T.N., Howe, J.A., Bayley, S.T., Ferguson, B., and Branton, P.E. 1988. Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol. Cell. Biol. 8: 3955-3959.
9. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R.R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K. W., and Vogelstein, B. 1993. WAFl, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
10. Eliyahu, D., Goldfinger, N., Pinhasi-Kimhi, O., Shaulski, G., Skurnik, Y, Arai, N., Rotter, V., and Oren, M. 1988. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3: 313-321.
11. Flaman, J.-M., Frebourg, T., Moreau, V., Charbonnier, F., Martin, C., Chappuis, P., Sappino, A.P., Limacher, J.-M., Bron, L., Benhattar, J., Tada, M., van Meir, E.G., Estreicher, A., and Iggo, R.D. 1995. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. U.S.A. 92: 3963-3967.
12. Harvey, D.M., and Levine, A.J. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5: 2375-2385.
13. Hermeking, H., Lengauer, C., Polyak, K., He, T.-C. Kinzler, K.W., and Vogelstein, B. 1997. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1: 3-11.
14. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. 1991. p53 mutations in human cancers. Science 253: 49-53.
15. Huang, T.S., Kuo, M.L., Shew, J.Y., Chou, Y.W., and Yang, W.K. 1996. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents. Oncogene 13: 625-632.
16. Ishioka, C., Frebourg, T., Yan. Y.-X., Vidal, M., Friend, S.H., Schmids, S., and Iggo, R. 1993. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet. 5: 124-129.
17. Kagiichi-Kimura, S., Yamashita, T., Yoshida, K., Ishida, S., Mori, M., and Fujinaga, K. 1997. Immortalization of rat primary cells by reciprocal complementations of human papillomavirus type 16 E7 and adenovirus type 5 E1A mutants. Tumor Res. 32: 1-21.
18. Kanda, T., Segawa, K., Ohuchi, N., Mori, S., and Ito, Y. 1994. Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site. Mol. Cell. Biol. 14: 2651-2663.
19. Kashiwazaki, H., Tonoki, H., Tada, M., Chiba, I., Shindoh, M., Totsuka, Y., Iggo, R., and Moriuchi, T. 1997. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 15: 2667-2674.
20. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., and Fornace, A.J., Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-598.
21. Kimura, G., Itagaki, A., and Summers, J. 1975. Rat cell line 3Y1 and its virogenic polyoma- and SV40-transformed derivatives. Int. J. Cancer 15: 694-706.
22. Lang, S., Marchesani, M., Servomaa, K., Kauppinen, L., Janne, J., Rytomaa, T., Wells, R., Luu, M., and Elkind, M.M. 1999. p53 gene mutations in neoplastic transformation of C3H 10T1/2 and severe combined immunodeficiency fibroblasts. Mutat. Res. 14: 61-65.
23. Levine, A.J., Perry, M.E., Chang, A., Silver, A., Dittmer, D., Wu, M., and Welsh, D. 1994. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer 69: 409-416.
24. Lowe, S.W., and Ruley, H.E. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7: 535-545.
25. McGrory, W.J., Bautista, D.S., and Graham, F.L. 1988. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163: 614-617.
26. Miyashita, T., and Reed, J.C. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
27. Mymryk, J.S. 1996. Tumor suppressive properties of the adenovirus 5 E1A oncogene. Oncogene 13: 1581-1589.
28. Mymryk, J.S., Shire, K., and Bayley, S.T. 1994. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene 9: 1187-1193.
29. Nakada, D., Ba, Y., Tsunematsu, I., Hamada, J., Tonoki, H., Kashiwazaki, H., Hosokawa, M., and Moriuchi, T. 1997. Proceedings of the 56th Japanese Cancer Association, pp. 306.
30. Nevins, J.R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429.
31. Nudel, U., Zakut, R., Shani, M., Neuman, S., Levy, Z., and Yaffe, D. 1983. The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucleic Acids Res. 11: 1759-1771.
32. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyl-transferases. Cell 87: 953-959.
33. Ory, K., Legros, Y., Auguin, C., and Soussi, T. 1994. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J. 13: 3496-3504.
34. Pietenpol, J.A., Tokino, T., Thiagalingam, S., El-Deiry, W.S., Kinzler, K.W., and Vogelstein, B. 1994. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. U.S.A. 91: 1998-2002.
35. Polyak, K., Waldman, T., He, T.-H., Kinzler, K.W., and Vogelstein, B. 1996. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10: 1945-1952.
36. Rao, L., Debbas, M., Sabbatini, P., Hockenberry, D., Korsmeyer, S., and White, E. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 89: 7742-7746.
37. Ricciardi, R.P. 1995. Transformation and tumorigenesis mediated by the adenovirus E1A and E1B oncogenes, p. 195-225. In Barbanti-Brodano, G. et al. (eds), DNA tumor viruses: oncogenic mechanisms. Plenum Press, New York.
38. Sakamuro, D., Sabbatini, P., White, E., and Prendergast, G.C. 1997. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15: 887-898.
39. Sato, N., Torigoe, T., Yagihashi, A., Okubo, M., Takahashi, S., Takahashi, N., Enomoto, K., Yamashita, T., Fujinaga, K., and Kikuchi, K. 1987. Assessment and establishment of a WKA rat fetus-derived cells for oncogene transfection and analysis of the transformation-associated antigens.Tumor Res. 22: 15-26.
40. Shan, B., and Lee, W.H. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166-8173.
41. Soussi, T., de Fromental, C.C., Breugnot, C., and May, E. 1988. Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res. 16: 11384.
42. Tada, M., Iggo, R.D., Ishii, N., Shinohe, Y., Sakuma, S., Estreicher, A., Sawamura, Y., and Abe, H. 1996. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay. Int. J. Cancer 67: 447-450.
43. Takahashi, M., Ilan, Y., Chowdhury, N.R., Guida, J., Horwitz, M., and Chowdhury, J.R. 1996. Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in gunn rats by administration of a recombinant adenovirus during the neonatal period. J. Biol. Chem. 271: 26536-26542.
44. Tzang, B.S., Lai, Y.C., Hsu, M., Chang, H.W., Chang, C.C., Huang, P.C., and Liu, Y.C. 1999. Function and sequence analyses of tumor suppressor gene p53 of CHO. K1 cells. DNA Cell Biol. 18: 315-321.
45. Ushijima, T., Makino, H., Nakayasu, M., Aonuma, S., Takeuchi, M., Segawa, K., Sugimura, T., and Nagao, M. 1994. Presence of p53 mutations in 3Y1-B clone 1-6: a rat cell line widely used as a normal immortalized fibroblast. Jpn. J. Cancer Res. 85: 455-458.
46. van der Eb, A.J., and Graham, F.L. 1975. Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65: 826-839.
47. van Ormondt, H., and Galibert, F. 1984. Nucleotide sequences of adenovirus DNAs. Curr. Top. Microbiol. Immunol. 110: 73-142.
48. Waridel, F., Estreicher, A., Bron, L., Flaman, J.M., Fontolliet, C., Monnier, P., Frebourg, T., and Iggo, R. 1997. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 16: 163-169.
49. White, E., and Cipriani, R. 1990. Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol. Cell. Biol. 10: 120-130.
50. White, E., Cipriani, R., Sabbatini, P., and Denton, A. 1991. Adenovirus E1B 19K-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65: 2968-2978.
51. Whyte, P., Ruley, H.E., and Harlow, E. 1988. Two regions of the adenovirus early region 1A proteins are required for transformation. J. Virol. 62: 257-265.
52. Whyte, P., Williamson, N.M., and Harlow, E. 1989. Cellular targets for transformation by the adenovirus E1A proteins. Cell 56: 67-75.
53. Wigler, M., Pellicer, A., Silverstein, S., Axel, R., and Urlaub, G., and Chasin, L. 1979. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 76: 1373-1376.
54. Wu, X.W., and Levine, A.J. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91: 3602-3606.
55. Yamashita, T., Segawa, K., Fujinaga, Y., Nishikawa, T., and Fujinaga, K. 1993. Biological and biochemical activity of E7 genes of the cutaneous human papilloma-virus type 5 and 8. Oncogene 8: 2433-2441.
56. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345-347.
57. Zerler, B., Moran, B., Maruyama, K., Moomaw, J., Grodzicker, T., and Ruley, H.E. 1986. Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Mol. Cell. Biol. 6: 887-899.
58. Zhang, W.-W., Fang, X., Mazur, W., French, B.A., Georges, R.N., and Roth, J.A. 1994. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1: 5-13.